Concise Review: Apoptotic Cell-Based Therapies-Rationale, Preclinical Results and Future Clinical Developments

Stem Cells

Volumn 34, Issue 6, 2016, Pages 1464-1473

  Saas, Philippe ^a,b,c   Daguindau, Etienne ^a,b,c,d   Perruche, Sylvain ^a,b,c  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^c LabEX LipSTIC   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Cell therapy; Efferocytosis; Graft versus host disease; Inflammation; Macrophages; Regulatory T cells; Sepsis; Tolerance; Transplantation

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; APOPTOSIS; APOPTOTIC CELL BASED THERAPY; CELL THERAPY; CELLS BY BODY ANATOMY; CLINICAL TRIAL (TOPIC); ENGRAFTMENT; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; MACROPHAGE; PHAGOCYTE; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; BIOLOGICAL MODEL; BIOLOGICAL THERAPY;

ANIMALS; APOPTOSIS; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOMODULATION; MODELS, BIOLOGICAL;

EID: 84963657648     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2361     Document Type: Review

References (80)

1. Ducloux D, Courivaud C, Bamoulid J, et al., Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation. J Am Soc Nephrol 2010; 21: 868-875.
2. Xia CQ, Peng R, Qiu Y, et al., Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 2007; 56: 2116-2123.
3. Xia CQ, Qiu Y, Peng RH, et al., Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice. J Autoimmun 2008; 30: 283-292.
4. Miyake Y, Asano K, Kaise H, et al., Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest 2007; 117: 2268-2278.
5. Qiu CH, Miyake Y, Kaise H, et al., Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 2009; 182: 4127-4136.
6. Gray M, Miles K, Salter D, et al., Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 2007; 104: 14080-14085.
7. Perruche S, Saas P, Chen W., Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: A potential cell-based therapy? Arthritis Res Ther 2009; 11: R104.
8. Notley CA, Brown MA, Wright GP, et al., Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 2011; 186: 4967-4972.
9. Notley CA, Brown MA, McGovern JL, et al., Engulfment of activated apoptotic cells abolishes TGF-beta-mediated immunoregulation via the induction of IL-6. J Immunol 2015; 194: 1621-1627.
10. Grau A, Tabib A, Grau I, et al., Apoptotic cells induce NF-kappaB and inflammasome negative signaling. PLoS One 2015; 10: e0122440.
11. Yoon YS, Kim SY, Kim MJ, et al., PPARgamma activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines. Mucosal Immunol 2015; 8: 1031-1046.
12. Lee YJ, Moon C, Lee SH, et al., Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction. European Resp J 2012; 40: 424-435.
13. Yoon YS, Lee YJ, Choi JY, et al., Coordinated induction of cyclooxygenase-2/prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis. J Leukoc Biol 2013; 94: 1037-1049.
14. Huynh ML, Fadok VA, Henson PM., Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41-50.
15. Ren Y, Xie Y, Jiang G, et al., Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol 2008; 180: 4978-4985.
16. Hotchkiss RS, Chang KC, Grayson MH, et al., Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 2003; 100: 6724-6729.
17. Kushwah R, Oliver JR, Zhang J, et al., Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J Immunol 2009; 183: 7104-7118.
18. Zhang M, Xu S, Han Y, et al., Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta. Hepatology 2011; 53: 306-316.
19. Griffith TS, Kazama H, VanOosten RL, et al., Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 2007; 178: 2679-2687.
20. Ferguson TA, Herndon J, Elzey B, et al., Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J Immunol 2002; 168: 5589-5595.
21. Sun E, Gao Y, Chen J, et al., Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 2004; 11: 1258-1264.
22. Wang Z, Larregina AT, Shufesky WJ, et al., Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6: 1297-1311.
23. Wang Z, Shufesky WJ, Montecalvo A, et al., In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One 2009; 4: e4940.
24. Mougel F, Bonnefoy F, Kury-Paulin S, et al., Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells. Diabetes Metab 2012; 38: 531-537.
25. Wu C, Zhang Y, Jiang Y, et al., Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells. Cell Mol Immunol 2013; 10: 393-402.
26. Bittencourt MC, Perruche S, Contassot E, et al., Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98: 224-230.
27. Perruche S, Kleinclauss F, Bittencourt Mde C, et al., Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 2004; 4: 1361-1365.
28. Kleinclauss F, Perruche S, Masson E, et al., Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13: 41-52.
29. Bonnefoy F, Masson E, Perruche S, et al., Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction. Leukemia 2008; 22: 1430-1434.
30. Bonnefoy F, Perruche S, Couturier M, et al., Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol 2011; 186: 5696-5705.
31. Ankersmit HJ, Hoetzenecker K, Dietl W, et al., Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 2009; 39: 445-456.
32. Lichtenauer M, Mildner M, Baumgartner A, et al., Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 2011; 106: 645-655.
33. Saas P, Kaminski S, Perruche S., Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases. Immunotherapy 2013; 5: 1055-1073.
34. Hannani D., Extracorporeal photopheresis: Tolerogenic or immunogenic cell death? Beyond current dogma. Front Immunol 2015; 6: 349.
35. McCarthy DP, Bryant J, Galvin JP, et al., Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. Am J Transplant 2015; 15: 1475-1483.
36. Poon IK, Lucas CD, Rossi AG, et al., Apoptotic cell clearance: Basic biology and therapeutic potential. Nat Rev Immunol 2014; 14: 166-180.
37. Arandjelovic S, Ravichandran KS., Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 2015; 16: 907-917.
38. Galluzzi L, Vitale I, Abrams JM, et al., Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
39. Rongvaux A, Jackson R, Harman CC, et al., Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 2014; 159: 1563-1577.
40. White MJ, McArthur K, Metcalf D, et al., Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 2014; 159: 1549-1562.
41. Kazama H, Ricci JE, Herndon JM, et al., Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32.
42. Lauber K, Bohn E, Krober SM, et al., Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717-730.
43. Chekeni FB, Elliott MR, Sandilos JK, et al., Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 2010; 467: 863-867.
44. Linkermann A, Stockwell BR, Krautwald S, et al., Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol 2014; 14: 759-767.
45. Chen W, Frank ME, Jin W, et al., TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001; 14: 715-725.
46. Gao Y, Herndon JM, Zhang H, et al., Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 1998; 188: 887-896.
47. Ariel A, Fredman G, Sun YP, et al., Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 2006; 7: 1209-1216.
48. Pupjalis D, Goetsch J, Kottas DJ, et al., Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling. EMBO Mol Med 2011; 3: 102-114.
49. Krispin A, Bledi Y, Atallah M, et al., Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood 2006; 108: 3580-3589.
50. Yamaguchi H, Maruyama T, Urade Y, et al., Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells. ELife 2014; 3: e02172.
51. Ariel A, Serhan CN., New lives given by cell death: Macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 2012; 3: 4.
52. Gregory CD, Pound JD., Cell death in the neighbourhood: Direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol 2011; 223: 177-194.
53. Oropesa Avila M, Fernandez Vega A, Garrido Maraver J, et al., Emerging roles of apoptotic microtubules during the execution phase of apoptosis. Cytoskeleton 2015; 72: 435-46.
54. Ravishankar B, Shinde R, Liu H, et al., Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc Natl Acad Sci USA. 2014; 111: 4215-4220.
55. Morelli AE, Larregina AT, Shufesky WJ, et al., Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood 2003; 101: 611-620.
56. Perruche S, Zhang P, Liu Y, et al., CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008; 14: 528-535.
57. McGaha TL, Karlsson MC., Apoptotic cell responses in the splenic marginal zone: A paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity. Immunol Rev 2016; 269: 26-43.
58. Lavin Y, Mortha A, Rahman A, et al., Regulation of macrophage development and function in peripheral tissues. Nat Rev Immunol 2015; 15: 731-744.
59. Idoyaga J, Fiorese C, Zbytnuik L, et al., Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 2013.
60. Desch AN, Randolph GJ, Murphy K, et al., CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 2011; 208: 1789-1797.
61. Juncadella IJ, Kadl A, Sharma AK, et al., Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 2012; 493: 547-551.
62. Millet A, Martin KR, Bonnefoy F, et al., Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest 2015; 125: 4107-4121.
63. A-Gonzalez N, Bensinger SJ, Hong C, et al., Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009; 31: 245-258.
64. Rebe C, Raveneau M, Chevriaux A, et al., Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages. Circ Res 2009; 105: 393-401.
65. Mukundan L, Odegaard JI, Morel CR, et al., PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 2009; 15: 1266-1272.
66. Vives-Pi M, Rodriguez-Fernandez S, Pujol-Autonell I., How apoptotic beta-cells direct immune response to tolerance or to autoimmune diabetes: A review. Apoptosis 2015; 20: 263-272.
67. Voll RE, Herrmann M, Roth EA, et al., Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350-351.
68. Fadok VA, Bratton DL, Konowal A, et al., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
69. Verbovetski I, Bychkov H, Trahtemberg U, et al., Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 2002; 196: 1553-1561.
70. Ronchetti A, Rovere P, Iezzi G, et al., Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999; 163: 130-136.
71. Mevorach D, Zhou JL, Song X, et al., Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 387-392.
72. Kasagi S, Zhang P, Che L, et al., In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci Transl Med 2014; 6: 241ra278.
73. Ludvigsson J, Faresjo M, Hjorth M, et al., GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008; 359: 1909-1920.
74. Ferrara JL, Levine JE, Reddy P, et al., Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
75. Saas P, Gaugler B, Perruche S., Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome. Ann NY Acad Sci 2010; 1209: 118-126.
76. Mevorach D, Zuckerman T, Reiner I, et al., Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: A phase I/IIa clinical trial. Biol Blood Marrow Transplant 2014; 20: 58-65.
77. Perruche S, Kleinclauss F, Angonin R, et al., A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, does not induce autoimmunity. J Hematother Stem Cell Res 2003; 12: 451-459.
78. Bondanza A, Zimmermann VS, Dell'Antonio G, et al., Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004; 50: 1549-1560.
79. Beer L, Zimmermann M, Mitterbauer A, et al., Analysis of the secretome of apoptotic peripheral blood mononuclear cells: Impact of released proteins and exosomes for tissue regeneration. Sci Rep 2015; 5: 16662.
80. Bagalkot V, Deiuliis JA, Rajagopalan S, et al., " Eat me" imaging and therapy. Adv Drug Deliv Rev 2016; 99: 2-11.